1[1]Konerding MA,Malkusch W,Klapthor B,et al.Evidence for characteristic vascular patterns in solid tumours:Quantitative studies using corrosion casts[J].Br J Cancer,1999,80:724-732.
2[2]Jain RK.Normalizing tumor vasculature with anti-angiogenic therapy:A new paradigm for combination therapy[J].Nat Med,2001,7:987-989.
3[3]Dvorak HF.Tumors Wounds that do not heal[J].N Engl J Med,1986,315:1650-1659.
4[4]Folkman J.Tumor angiogenesis and tissue factor[J].Nat Med,1996,2:167-168.
5[5]O'Reilly MS,Holmgren L,Chen C,et al.Angiostatin induces and sustains dormancy of human primary tumors in mice[J].Nat Med,1996,2:689-692.
6[6]Weichselbaum,R.R.Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head-and neck-cancer patients[J].Proc Natl Acad Sci USA,1986,83:2684-2688.
7[7]Weichselbaum R.R.,Beckett M.A.,Dahlberg,W.et al.Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones[J].Int J Radiat Oncol Biol Phys,1988,14:907-912.
9[9]Lund EL,Bastholm L,Kristjansen PE.Therapeutic synergy of TNP-470 and ionizing radiation:Effects on tumor growth,vessel morphology,and angiogenesis in human glioblastoma multiforme xenografts[J].Clin Cancer Res,2000,6:971-978.
10[10]Helena.J.Combined effects of angiostatin and ionizing radiation in antitumour therapy[J].Nature,1998,394:(16)287-291.
4Folkman J. Role of angiogenesis in tumor growth and metastasis.Semin Oncol,2002,29(6 Suppl 16) : 15-18.
5Huang X, Wong MK, Zhao Q, et al. Soluble recombinant endostatinpurified from Escherichia coli: antiangiogenic activity and antitumor effect. Cancer Res,2001,61(2): 478-481. Erratum in:Cancer Res, 2001,61 ( 15 ) : 5956. Cancer Res, 2001,61 (10) :4297.
6Li B, Wu XY, Zhou H, et al. Acid-induced unfolding mechanism of recombinant human endostatin. Biochemistry, 2004, 43 (9) :2550-2557.
7Eder JP Jr, Supko JG, Clark JW, et al. Phase Ⅰ clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J Clin Oncol, 2002,20(18) : 3772-3784.
8Kulke M, Bergsland E, Ryan DP, et al. A phase Ⅱ , open-label,safety, pharmacokinetic, and efficacy study of recombinant human endostatin in patients with advanced neuroendocrine tumors. Proc ASCO,2003,22: 958a.
9Scagliotti GV, De Marinis F, Rinaldi M, et al. Phase Ⅲ randomized trial comparing three platinum-based doublets in advanced nonsmall cell lung cancer. J Clin Oncol,2002,20(21) : 4285-4291.
10Gebbia V, Galetta D, Caruso M, et al. Gemcitabine and cisplatin versus vinorelbine and cisplatin versus ifosfamide+gemcitabine fol lowed by vinorelbine and cisplatin versus vinorelbine and cisplatin followed by ifosfamide and gemcitabine in stage Ⅲ B-Ⅳ non small cell lung carcinoma: a prospective randomized phase Ⅲ trial of the Gruppo Oncologico Italia Meridionale. Lung Cancer,2003,39(2) :179-189.
